Association of beta blocker plus amiodarone use and improved survival after a myocardial infarction

A pooled analysis of patients in the EMIAT and CAMIAT trials shows that all-cause mortality after a myocardial infarction is lower with a combination of amiodarone and a beta blocker compared with beta blocker alone or no beta blocker with or without amiodarone.